The pioneering clinical trial is part of a large European Union funded project and involved 311 patients across 11 sites in four countries (Finland, Germany, the Netherlands and Sweden). The trial involved patients with prodromal Alzheimer’s (often referred to as Mild Cognitive Impairment or MCI). Patients were randomised to receive either the nutritional intervention or an iso-caloric control drink for 24 months.
from Dementia Big http://ift.tt/2zjgrSe via alcoholic dementia
http://ift.tt/2zmvRoM
No comments:
Post a Comment